Checked.be · Company dossierhttps://checked.be/en/c/farmacon-0439169181 · as of 19-11-2026
FARMACON
ActivePrivate limited company · founded 1989 · active for 36 yearsGentse Steenweg 450, 9160 LokerenKBO/BCE: BE 0439.169.181subsidiary of Name hiddenVisible after signing in
Save to list
Keep companies in your own lists to find and compare them later. All it takes is a free account.
Seven of the last ten came late. The 2019 accounts came in latest, 33 days after the end of the period.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 3,986 companies had the same profile as FARMACON has now. Each dot stands for 10 companies, two years later.
96.4%
were still trading
2.3%
stopped another way
1.1%
went bankrupt
Micro
20 years or older
solvency 10 to 30%
a profit under 5% of the balance sheet
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,986 companies, not a prediction for FARMACON. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Signal hidden, visible after signing inVisible after signing in
Hidden signalVisible after signing in
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Hidden signalVisible after signing in
Board and ownership
Name after signing inVisible after signing in
Director, Name hiddenVisible after signing in
Hidden nameVisible after signing in
Director
Name after signing inVisible after signing in 99.73%score XXVisible after signing inequity €395,746 (2025) · annual accounts 30-06-2025 of Hidden nameVisible after signing in
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0439169181
Capital increase of €585,000 to €1,170,000
The capital rose from €585,000 to €1,170,000 · Capital contribution: inbreng gedeelte vaststaande schuldvordering rekening-courant · Hidden nameVisible after signing in (director) and Name after signing inVisible after signing in (director) reappointed · General meeting of 27-02-2024 · Gazette deed
Capital increase of €191,250 to €585,000
The capital rose from €393,750 to €585,000 · General meeting of 08-07-2013 · Gazette deed
Capital increase of €375,150 to €393,750
The capital rose from €18,600 to €393,750 · Name hiddenVisible after signing in appointed as manager · Hidden nameVisible after signing in and Name after signing inVisible after signing in act as permanent representatives · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as FARMACON: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €885,000 and €1.2m, founded between 1988 and 1989.
The company number of FARMACON is 0439.169.181. The VAT number is the same number with BE in front: BE 0439.169.181.
Where is FARMACON based?
The registered office is at Gentse Steenweg 450, 9160 Lokeren.Company details
What does FARMACON do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of FARMACON?
FARMACON is a private limited company (BV).
When was FARMACON founded?
FARMACON was founded on 15-12-1989.
Is FARMACON still active?
Yes, FARMACON is an active enterprise in the KBO register.
How many employees does FARMACON have?
FARMACON had an average of 2.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does FARMACON fall under?
In its 2025 annual accounts, FARMACON states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of FARMACON?
The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €293,299 and 42 comparable companies (NACE 477). It probably lies between €800,000 and €1.4m.
Is FARMACON profitable?
In financial year 2025, FARMACON made a profit of €16,845.
Where can I find the annual accounts of FARMACON?
FARMACON filed 36 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of FARMACON due?
FARMACON must file the annual accounts for financial year 2026 by 31-07-2027.Timeline